- Viral vectors as vaccine platforms: deployment in sightChristine S Rollier
Oxford Vaccine Group, Department of Paediatrics, Center for Clinical Vaccine and Tropical Medicine, University of Oxford, Churchill Hospital, Churchill Drive, Oxford OX3 7LJ, United Kingdom
Curr Opin Immunol 23:377-82. 2011....
- Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primatesAlexandra J Spencer
The Jenner Institute, University of Oxford, Oxford, United Kingdom
PLoS ONE 7:e33555. 2012..This report demonstrates that antigen multimerization using IMX313 is a simple and effective cross-species method to improve vaccine immunogenicity with potentially broad applicability...
- CD8+ T effector memory cells protect against liver-stage malariaArturo Reyes-Sandoval
The Jenner Institute, University of Oxford, Oxford OX3 7DQ, United Kingdom
J Immunol 187:1347-57. 2011..Thus, we identify persistent CD8 T(EM) populations as essential for vaccine-induced pre-erythrocytic protection against malaria, a finding that has important implications for vaccine design...